Vulnerabilities

Vulnerability · CVE-2026-27002

OpenClaw is a personal AI assistant.

Published Feb 20, 2026 · catalog updated Jun 17, 2026 · OpenClaw is a personal

Check if you run it

No confirmed exploitation is on record for CVE-2026-27002. EPSS is 0.75%. Act only if a listed version of OpenClaw is a personal is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (OpenClaw is a personal).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High7.7
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.75%
Remediation
Advisory link
Affected products
cpe openclaw/openclaw

OpenClaw is a personal AI assistant. Prior to version 2026.2.15, a configuration injection issue in the Docker tool sandbox could allow dangerous Docker options (bind mounts, host networking, unconfined profiles) to be applied, enabling container escape or host data access. OpenClaw 2026.2.15 blocks dangerous sandbox Docker settings and includes runtime enforcement when building args; config-schema validation for , , ; and security audit findings to surface dangerous sandbox docker config. As a workaround, do not configure to mount system directories or Docker socket paths, keep at (default) or , and do not use for seccomp/AppArmor profiles.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe openclaw/openclawversion unspecified

How to fix CVE-2026-27002

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-27002. EPSS is 0.75%. Act only if a listed version of OpenClaw is a personal is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-250: Execution with Unnecessary Privileges. EPSS 0.75%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Feb 20, 2026 · NIST NVD

    Detected

    OpenClaw is a personal AI assistant. Prior to version 2026.2.15, a configuration injection issue in the Docker tool sandbox could allow dangerous Docker options (bind mounts, host networking, unconfined profiles) to be applied, enabling container escape or host data access. OpenClaw 2026.2.15 blocks dangerous sandbox Docker settings and includes runtime enforcement when building args; config-schem

  2. Jun 17, 2026 · NIST NVD

    Updated

    OpenClaw is a personal AI assistant. Prior to version 2026.2.15, a configuration injection issue in the Docker tool sandbox could allow dangerous Docker options (bind mounts, host networking, unconfined profiles) to be applied, enabling container escape or host data access. OpenClaw 2026.2.15 blocks dangerous sandbox Docker settings and includes runtime enforcement when building args; config-schem

Sources

  • CVE.orgVulnerability recordCVE-2026-27002

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-27002

    30-day exploitation probability 0.8%

    first.org
  • NIST NVDVulnerability recordCVE-2026-27002

    OpenClaw is a personal AI assistant. Prior to version 2026.2.15, a configuration injection issue in the Docker tool sandbox could allow dangerous Docker options (bind mounts, host networking, unconfined profiles) to be applied, enabling container escape or host data access. OpenC

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.